(Q46697483)

English

Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Li-Li Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

Jie Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

Ge-Fei Lei

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

Gui-Ju Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

Yu-Wei Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

Ruo-Peng Sun

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

publication date

16 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

Basic and Clinical Pharmacology and Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

102

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

527-532

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Attention-deficit/hyperactivity disorder: a selective overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Conditional associative learning of spatial and object information in children with attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Age-related decline in water maze learning and memory in rats: strain differences.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Deficits of spatial learning and working memory in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Dopamine genes and ADHD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning mesocorticolimbic system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Effects of histamine H(3) receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

The role of histamine and the tuberomamillary nucleus in the nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

The histamine H3 receptor: from gene cloning to H3 receptor drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Gender differences in Morris water maze performance depend on task parameters.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Evidence for activation of histamine H3 autoreceptors during handling stress in the prefrontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder--the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

The physiology of brain histamine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Improvement by FUB 181, a novel histamine H3-receptor antagonist, of learning and memory in the elevated plus-maze test in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Central histaminergic system and cognition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Histamine H(3) receptors depress synaptic transmission in the corticostriatal pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Histaminergic facilitation of electrocorticographic activation: role of basal forebrain, thalamus, and neocortex.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) -- the spontaneously hypertensive rat (SHR).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00230.X

21 January 2018

Identifiers

10.1111/J.1742-7843.2008.00230.X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18346050

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46697483&oldid=1510741360"